ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.060
-0.040 (-3.64%)
At close: Jun 11, 2026, 4:00 PM EDT
1.060
0.00 (0.00%)
Pre-market: Jun 12, 2026, 6:08 AM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$410,233
Profits / Employee
-$709,788
Market Cap
134.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 193 | -72 | -27.17% | 188 | 5 |
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
Employee RankingsADCT News
- 4 days ago - ADC Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 7 days ago - ADC Therapeutics price target lowered to $5 from $8 at Stephens - TheFly
- 7 days ago - ADC Therapeutics plunges after patient deaths in blood cancer drug trial - Reuters
- 8 days ago - ADC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 8 days ago - ADC Therapeutics Transcript: Study result - Transcripts
- 8 days ago - ADC Therapeutics Slides: Study result - Filings
- 8 days ago - ADC Therapeutics Press release: Study result - Filings
- 8 days ago - ADC Therapeutics’ Zynlonta combination shows survival efficacy in DLBCL - TheFly